Extending visit intervals for clinically stable patients on antiretroviral therapy: Multicohort analysis of HIV programs in Southern Africa
Journal of Acquired Immune Deficiency Syndromes | Jul 01, 2019
Pregnancy and neonatal outcomes following prenatal exposure to dolutegravir
Journal of Acquired Immune Deficiency Syndromes | Jul 01, 2019
Switching to doravirine/lamivudine/tenofovir disoproxil fumarate (DOR/3TC/TDF) maintains HIV-1 virologic suppression through 48 weeks: Results of the DRIVE-SHIFT trial
Journal of Acquired Immune Deficiency Syndromes | Jun 29, 2019
Most read this week